Paper Details

  1. Home
  2. Paper Details

Treatment Considerations for CNS Infections Caused by Vancomycin-Resistant <i>Enterococcus faecium</i>: A Focused Review of Linezolid and Daptomycin.

Author: HodgsonHayley A, LeeBenjamin J, SeddonAmanda N, VuBetty N, WangSheila K

Journal ArticleAn article published in an academic or professional journal that reports original research or scholarly analysis.
ReviewAn article that critically examines existing research on a particular topic and summarizes the current state of knowledge in the field.

Overview

Linezolid and daptomycin are potential treatment options for central nervous system infections caused by vancomycin-resistant Enterococcus faecium. This review provides a summary of the current literature describing the pharmacology, pharmacokinetics, efficacy, and safety of these drugs.
Paper Details　
Original Abstract of the Article :
Label="OBJECTIVE">To review the current literature describing pharmacology, pharmacokinetics/pharmacodynamics (PK/PD), efficacy, and safety of linezolid and daptomycin for the treatment of central nervous system (CNS) infections caused by vancomycin-resistant <i>Enterococcus</i> (VRE) <i>faecium</i>...See full text at original site
Dr.Camel IconDr.Camel's Paper Summary Blogラクダ博士について

ラクダ博士は、Health Journal が論文の内容を分かりやすく解説するために作成した架空のキャラクターです。
難解な医学論文を、専門知識のない方にも理解しやすいように、噛み砕いて説明することを目指しています。

* ラクダ博士による解説は、あくまで論文の要点をまとめたものであり、原論文の完全な代替となるものではありません。詳細な内容については、必ず原論文をご参照ください。
* ラクダ博士は架空のキャラクターであり、実際の医学研究者や医療従事者とは一切関係がありません。
* 解説の内容は Health Journal が独自に解釈・作成したものであり、原論文の著者または出版社の見解を反映するものではありません。


引用元：
https://doi.org/10.1177/1060028020932513

データ提供：米国国立医学図書館（NLM）

Vancomycin-Resistant Enterococcus Faecium: A New Desert Storm in CNS Infections

The world of infectious diseases is a complex desert, filled with challenging foes like vancomycin-resistant Enterococcus faecium (VRE). These bacteria, like a fierce sandstorm, can cause serious infections, particularly in the central nervous system (CNS). This research is dedicated to finding effective weapons to combat VRE infections, focusing on two potential solutions: linezolid and daptomycin. The study aims to understand the effectiveness and safety of these medications in treating CNS infections caused by VRE. The researchers found that both linezolid and daptomycin showed promising results in treating CNS infections caused by VRE, demonstrating their potential as valuable weapons in the fight against these resistant bacteria.

Linezolid and Daptomycin: Fighting the VRE Sandstorm in the CNS

The study provides evidence for the effectiveness and safety of linezolid and daptomycin in treating CNS infections caused by VRE. This research contributes to the ongoing battle against drug-resistant bacteria, offering hope for patients facing these challenging infections.

Armored Against Infection: Navigating the Desert of Drug Resistance

The findings suggest that linezolid and daptomycin can effectively fight VRE infections in the CNS, like brave warriors battling a sandstorm. This research is crucial for developing effective strategies against drug-resistant bacteria and ensuring a safe and healthy journey through the desert of infectious diseases.

Dr.Camel's Conclusion

In the vast desert of infectious diseases, vancomycin-resistant Enterococcus faecium (VRE) is a formidable foe. This study sheds light on the potential of linezolid and daptomycin, like powerful weapons, to effectively combat VRE infections in the central nervous system, offering a beacon of hope in the fight against drug-resistant bacteria.

Date :
  1. Date Completed 2020-12-25
  2. Date Revised 2020-12-25
Further Info :

Pubmed ID

32506921

DOI: Digital Object Identifier

10.1177/1060028020932513

Related Literature

Article Analysis
・Effects of daptomycin injection
SNS
PICO Info
in preparation
Languages

English

Positive IndicatorAn AI analysis index that serves as a benchmark for how positive the results of the study are. Note that it is a benchmark and requires careful interpretation and consideration of different perspectives.

This site uses cookies. Visit our privacy policy page or click the link in any footer for more information and to change your preferences.